Estados financieros detallados de Editas Medicine, Inc. (EDIT): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Editas Medicine, Inc. registró ingresos de $40.5M en el último ejercicio fiscal, con un CAGR de 5 años del -14.9%.
Márgenes de los últimos 12 meses: margen bruto 56.9%, margen operativo -174.7%, margen neto -157.3%.
Al precio actual de $2.71, EDIT presenta beneficios negativos (P/E no significativo) y un ROE del -196.63%. La capitalización bursátil es de $416M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $6.1M | $13.7M | $31.9M | $20.5M | $90.7M | $25.5M | $19.7M | $78.1M | $32.3M | $40.5M |
| Coste de Ventas | $57.0M | $83.2M | $90.7M | $96.9M | $158.0M | $5.1M | $6.3M | $6.1M | $199.2M | 0 |
| Beneficio Bruto | -$50.9M | -$69.4M | -$58.7M | -$76.4M | -$67.3M | $20.5M | $13.4M | $72.1M | -$166.9M | $40.5M |
| I+D | $57.0M | $83.2M | $90.7M | $96.9M | $158.0M | $142.5M | $175.0M | $177.7M | $199.2M | $90.0M |
| Generales y Administrativos | $46.3M | $50.5M | $55.0M | $64.6M | $67.6M | $76.2M | $70.7M | $69.7M | $72.0M | $49.9M |
| Gastos Operativos | $103.2M | $133.7M | $145.7M | $64.6M | $67.6M | $213.6M | $239.3M | $241.2M | $84.2M | $139.9M |
| Beneficio Operativo | -$97.2M | -$119.9M | -$113.7M | -$140.9M | -$134.8M | -$193.1M | -$225.9M | -$169.2M | -$251.2M | -$99.3M |
| EBITDA | -$96.1M | -$116.7M | -$110.5M | -$138.1M | -$130.9M | -$187.4M | -$214.1M | -$147.2M | -$233.1M | -$148.6M |
| Gastos por Intereses | 0 | $978000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $6.2M |
| Beneficio Antes de Impuestos | -$97.2M | -$120.3M | -$110.0M | -$133.7M | -$116.0M | -$192.5M | -$220.4M | -$153.2M | -$237.1M | -$160.1M |
| Impuestos | 0 | -$1.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$97.2M | -$120.3M | -$110.0M | -$133.7M | -$116.0M | -$192.5M | -$220.4M | -$153.2M | -$237.1M | -$160.1M |
| BPA | $-3.02 | $-2.98 | $-2.33 | $-2.47 | $-1.98 | $-2.85 | $-3.21 | $-2.02 | $-2.88 | $-1.80 |
| BPA Diluido | $-3.02 | $-2.98 | $-2.33 | $-2.47 | $-1.98 | $-2.85 | $-3.21 | $-2.02 | $-2.88 | $-1.80 |
| Acciones en Circulación (Diluidas) | $32.2M | $40.3M | $47.1M | $50.0M | $58.6M | $67.6M | $68.7M | $76.0M | $82.3M | $88.7M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $7.5M | $24.7M | $2.8M | $11.9M |
| Beneficio Bruto | -$12.2M | $24.7M | $2.3M | $11.9M |
| Beneficio Operativo | -$24.5M | -$14.0M | -$25.0M | -$18.6M |
| EBITDA | -$22.0M | -$5.3M | -$23.4M | -$19.5M |
| Beneficio Neto | -$25.1M | -$5.6M | -$25.0M | -$18.2M |
| BPA | $-0.28 | $-0.06 | $-0.26 | $-0.15 |
| BPA Diluido | $-0.28 | $-0.06 | $-0.26 | $-0.15 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $185.3M | $146.6M | $134.8M | $238.2M | $139.7M | $203.5M | $141.5M | $123.7M | $131.5M | $146.6M |
| Inversiones a Corto | 0 | $182.5M | $234.2M | $219.0M | $262.4M | $296.3M | $202.8M | $199.5M | $138.4M | 0 |
| Cuentas por Cobrar | $88000 | $679000 | $30000 | $418000 | $6.0M | $267000 | $5.1M | $10.2M | $16.3M | $15.2M |
| Inventario | $1.7M | $1.9M | $2.9M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $187.2M | $332.2M | $374.8M | $463.8M | $419.1M | $507.3M | $356.8M | $340.8M | $289.3M | $163.9M |
| Inmovilizado Material | $40.4M | $39.4M | $40.2M | $39.6M | $39.1M | $43.3M | $59.2M | $45.7M | $47.1M | $19.7M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $229.2M | $373.3M | $420.4M | $508.9M | $572.6M | $677.5M | $514.3M | $499.2M | $341.6M | $186.5M |
| Cuentas por Pagar | $4.6M | $4.0M | $5.3M | $5.8M | $6.4M | $5.0M | $9.5M | $8.3M | $5.5M | $2.6M |
| Deuda a Corto | $10.0M | $7.5M | 0 | 0 | 0 | 0 | 0 | $12.0M | 0 | $11.0M |
| Pasivos Corrientes | $33.1M | $36.7M | $35.9M | $60.0M | $58.2M | $46.9M | $60.1M | $63.2M | $77.2M | $46.2M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $53.6M |
| Pasivos Totales | $94.6M | $165.2M | $184.2M | $246.4M | $179.0M | $123.8M | $153.6M | $150.1M | $207.3M | $159.2M |
| Reservas | -$185.5M | -$305.9M | -$416.3M | -$549.2M | -$665.2M | -$857.7M | -$1.08B | -$1.23B | -$1.47B | -$1.63B |
| Patrimonio Neto | $134.6M | $208.1M | $236.2M | $262.4M | $393.6M | $553.6M | $360.7M | $349.1M | $134.3M | $27.3M |
| Deuda Total | $35.1M | $33.4M | $32.4M | $29.1M | $26.1M | $26.4M | $43.9M | $48.5M | $35.0M | $76.7M |
| Deuda Neta | -$150.2M | -$295.7M | -$336.5M | -$428.1M | -$376.0M | -$473.5M | -$300.3M | -$274.6M | -$234.9M | -$69.9M |
| Capital Circulante | $154.1M | $295.5M | $338.9M | $403.9M | $360.9M | $460.4M | $296.6M | $277.6M | $212.1M | $117.6M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $165.6M | $146.6M | $123.6M | $181.8M |
| Activos Totales | $201.8M | $186.5M | $149.3M | $237.4M |
| Pasivos Totales | $188.3M | $159.2M | $144.9M | $132.1M |
| Patrimonio Neto | $13.5M | $27.3M | $4.4M | $105.3M |
| Deuda Total | $19.7M | $76.7M | $72.0M | $15.5M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$97.2M | -$120.3M | -$110.0M | -$133.7M | -$116.0M | -$192.5M | -$220.4M | -$153.2M | -$237.1M | -$160.1M |
| Amortizaciones | $1.2M | $2.7M | $3.3M | $2.8M | $4.0M | $5.1M | $6.3M | $6.1M | $5.8M | $5.3M |
| Compensación en Acciones | $16.9M | $23.4M | $26.6M | $27.2M | $23.2M | $43.4M | $29.3M | $19.8M | $21.4M | $10.0M |
| Cambio en Capital Circulante | $18.5M | $70.7M | $26.9M | $65.9M | -$102.2M | -$21.4M | $8.2M | -$1.6M | $3.5M | -$31.2M |
| Flujo de Caja Operativo | -$49.9M | -$9.4M | -$45.7M | -$40.7M | -$179.8M | -$163.8M | -$177.3M | -$132.2M | -$210.3M | -$165.2M |
| Inversiones (CapEx) | -$3.5M | -$2.1M | -$4.8M | -$6.2M | -$7.2M | -$8.0M | -$4.1M | -$4.7M | -$8.8M | -$607000 |
| Adquisiciones | $20000 | $15000 | $37000 | $102000 | $12000 | $46.5M | $18000 | 0 | 0 | $269000 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$53.4M | -$11.5M | -$50.5M | -$46.8M | -$187.0M | -$171.8M | -$181.5M | -$136.9M | -$219.1M | -$165.8M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$30.8M | -$36.4M | -$23.1M | -$29.6M |
| Inversiones (CapEx) | -$433000 | -$60000 | -$92000 | -$106000 |
| Flujo de Caja Libre | -$31.3M | -$36.4M | -$23.2M | -$29.7M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $2.2M | $2.1M | $2.1M | $2.2M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | +126.8% | +132.6% | -35.7% | +341.9% | -71.8% | -22.8% | +296.3% | -58.6% | +25.4% |
| Crecimiento Beneficio Neto (anual) | | -23.8% | +8.6% | -21.6% | +13.3% | -66.0% | -14.5% | +30.5% | -54.7% | +32.5% |
| Crecimiento BPA (anual) | | +1.3% | +21.8% | -6.0% | +19.8% | -43.9% | -12.6% | +37.1% | -42.6% | +37.5% |
| Cambio en Acciones (anual) | | +25.2% | +16.8% | +6.1% | +17.3% | +15.4% | +1.5% | +10.6% | +8.4% | +7.8% |
| Crecimiento FCF (anual) | | +78.5% | -339.7% | +7.2% | -299.3% | +8.1% | -5.6% | +24.6% | -60.1% | +24.3% |
| Margen Bruto | -841.3% | -505.8% | -183.9% | -372.0% | -74.1% | 80.2% | 67.9% | 92.2% | -516.6% | 100.0% |
| Margen Operativo | -1605.6% | -873.6% | -356.1% | -686.4% | -148.6% | -756.1% | -1146.3% | -216.6% | -777.2% | -245.2% |
| Margen EBITDA | -1587.1% | -849.8% | -345.9% | -672.6% | -144.3% | -733.8% | -1086.1% | -188.4% | -721.4% | -366.8% |
| Margen Neto | -1605.5% | -876.5% | -344.3% | -651.4% | -127.8% | -753.6% | -1118.3% | -196.1% | -733.7% | -395.0% |
| Margen FCF | -882.5% | -83.6% | -158.0% | -228.1% | -206.1% | -672.5% | -920.6% | -175.2% | -678.1% | -409.3% |
| Tasa Impositiva Efectiva | -0.0% | 0.9% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-1.66 | $-0.28 | $-1.07 | $-0.94 | $-3.19 | $-2.54 | $-2.64 | $-1.80 | $-2.66 | $-1.87 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $32.2M | $40.3M | $47.1M | $50.0M | $58.6M | $67.6M | $68.7M | $76.0M | $82.3M | $88.7M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -196.63% |
| Rentabilidad sobre capital invertido | -46.81% |
| Rentabilidad sobre activos | -31.15% |
| Margen bruto | 56.90% |
| Margen operativo | -174.71% |
| Margen neto | -157.32% |
Salud financiera
| Deuda / Patrimonio | 0.15 |
| Ratio corriente | 3.19 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -5.37 | -10.31 | -9.76 | -11.99 | -35.41 | -9.32 | -2.76 | -5.01 | -0.44 | -1.14 |
| P/VC | 3.88 | 5.96 | 4.54 | 5.64 | 10.44 | 3.24 | 1.69 | 2.20 | 0.78 | 6.67 |
| P/V | 86.39 | 90.26 | 33.55 | 72.09 | 45.29 | 70.28 | 30.90 | 9.85 | 3.24 | 4.49 |
| Margen Bruto | -841.3% | -505.8% | -183.9% | -372.0% | -74.1% | 80.2% | 67.9% | 92.2% | -516.6% | 100.0% |
| Margen Operativo | -1605.6% | -873.6% | -356.1% | -686.4% | -148.6% | -756.1% | -1146.3% | -216.6% | -777.2% | -245.2% |
| Margen Neto | -1605.5% | -876.5% | -344.3% | -651.4% | -127.8% | -753.6% | -1118.3% | -196.1% | -733.7% | -395.0% |